Agilent Posts Q2 Revenue of $1.84B, EPS $1.49, Raises Outlook
A•Agilent posted Q2 non-GAAP EPS of $1.49, beating consensus by $0.09 on revenue of $1.84 billion, up 10% year-over-year. The company raised its full-year profit forecast and shares hit their highest since 2002 after a Bank of America Buy upgrade to a $145 target.
1. Q2 Earnings Beat
Agilent reported non-GAAP EPS of $1.49 for fiscal Q2, surpassing consensus by $0.09, on revenue of $1.84 billion, marking 10% year-over-year growth driven by strength in pharmaceutical and chemical end markets.
2. Full-Year Forecast Raise
Following the strong quarterly results, Agilent lifted its adjusted profit forecast for fiscal 2026, citing sustained demand for lab equipment and solid execution across life sciences and industrial segments.
3. Share Response and Upgrade
Shares rallied to their highest level since 2002, retaking the 200-day moving average, as Bank of America upgraded Agilent to Buy with a $145 price target, highlighting the attractive valuation and broad-based performance.
